FOXD4L3
gene geneOn this page
Also known as OTTHUMG00000019959FOXD6
Summary
FOXD4L3 (forkhead box D4 like 3, HGNC:18523) is a protein-coding gene on chromosome 9q21.11, encoding Forkhead box protein D4-like 3 (Q6VB84).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in anatomical structure morphogenesis; cell differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.
Source: NCBI Gene 286380 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 119 total
- MANE Select transcript:
NM_199135
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18523 |
| Approved symbol | FOXD4L3 |
| Name | forkhead box D4 like 3 |
| Location | 9q21.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTTHUMG00000019959, FOXD6 |
| Ensembl gene | ENSG00000187559 |
| Ensembl biotype | protein_coding |
| OMIM | 611086 |
| Entrez | 286380 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000342833
RefSeq mRNA: 1 — MANE Select: NM_199135
NM_199135
CCDS: CCDS43833
Canonical transcript exons
ENST00000342833 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001702443 | 68302867 | 68305084 |
Expression profiles
Bgee: expression breadth broad, 39 present calls, max score 68.18.
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 68.18 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 58.61 | gold quality |
| primary visual cortex | UBERON:0002436 | 52.47 | gold quality |
| Ammon’s horn | UBERON:0001954 | 50.21 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.78 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 49.44 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 48.56 | gold quality |
| cerebral cortex | UBERON:0000956 | 47.71 | gold quality |
| frontal cortex | UBERON:0001870 | 47.23 | gold quality |
| granulocyte | CL:0000094 | 45.39 | silver quality |
| prefrontal cortex | UBERON:0000451 | 45.13 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 44.82 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 44.55 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 43.93 | gold quality |
| cerebellar cortex | UBERON:0002129 | 43.61 | gold quality |
| cerebellum | UBERON:0002037 | 43.57 | gold quality |
| putamen | UBERON:0001874 | 43.47 | gold quality |
| brain | UBERON:0000955 | 43.06 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 42.92 | silver quality |
| nucleus accumbens | UBERON:0001882 | 42.49 | gold quality |
| ganglionic eminence | UBERON:0004023 | 41.17 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.11 | gold quality |
| caudate nucleus | UBERON:0001873 | 41.00 | gold quality |
| bone marrow cell | CL:0002092 | 39.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.33 | gold quality |
| temporal lobe | UBERON:0001871 | 39.32 | gold quality |
| lymph node | UBERON:0000029 | 39.06 | gold quality |
| amygdala | UBERON:0001876 | 38.94 | gold quality |
| substantia nigra | UBERON:0002038 | 38.26 | gold quality |
| hypothalamus | UBERON:0001898 | 37.19 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.49 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The molecular landscape of well differentiated retroperitoneal liposarcoma. (PMID:34156092)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Foxd4 | ENSMUSG00000051490 |
Paralogs (41): FOXP3 (ENSG00000049768), FOXC1 (ENSG00000054598), FOXJ2 (ENSG00000065970), FOXF1 (ENSG00000103241), FOXN1 (ENSG00000109101), FOXM1 (ENSG00000111206), FOXP1 (ENSG00000114861), FOXO3 (ENSG00000118689), FOXA2 (ENSG00000125798), FOXA1 (ENSG00000129514), FOXJ1 (ENSG00000129654), FOXK2 (ENSG00000141568), FOXO1 (ENSG00000150907), FOXH1 (ENSG00000160973), FOXQ1 (ENSG00000164379), FOXK1 (ENSG00000164916), FOXD4 (ENSG00000170122), FOXA3 (ENSG00000170608), FOXB1 (ENSG00000171956), FOXR1 (ENSG00000176302), FOXL1 (ENSG00000176678), FOXC2 (ENSG00000176692), FOXE1 (ENSG00000178919), FOXS1 (ENSG00000179772), FOXL2 (ENSG00000183770), FOXO4 (ENSG00000184481), FOXD4L1 (ENSG00000184492), FOXD4L4 (ENSG00000184659), FOXD2 (ENSG00000186564), FOXI2 (ENSG00000186766), FOXE3 (ENSG00000186790), FOXD3 (ENSG00000187140), FOXR2 (ENSG00000189299), FOXJ3 (ENSG00000198815), FOXO6 (ENSG00000204060), FOXB2 (ENSG00000204612), FOXD4L5 (ENSG00000204779), FOXI3 (ENSG00000214336), FOXL3 (ENSG00000248767), FOXD1 (ENSG00000251493)
Protein
Protein identifiers
Forkhead box protein D4-like 3 — Q6VB84 (reviewed: Q6VB84)
All UniProt accessions (1): Q6VB84
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (1): NP_954586* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001766 | Fork_head_dom | Domain |
| IPR018122 | TF_fork_head_CS_1 | Conserved_site |
| IPR030456 | TF_fork_head_CS_2 | Conserved_site |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR050211 | FOX_domain-containing | Family |
Pfam: PF00250
UniProt features (12 total): sequence conflict 6, region of interest 2, compositionally biased region 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6VB84-F1 | 57.01 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
BENPORATH_ES_WITH_H3K27ME3, chr9q21, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR302C_5P, MIR3143, MIR507, MIR557, MIR4517, MIR4267, MIR9500, MIR142_3P, MIR329_5P, MIR31_5P, MIR6768_3P
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), anatomical structure morphogenesis (GO:0009653), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| developmental process | 1 |
| anatomical structure development | 1 |
| cellular developmental process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
446 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOXD4L3 | ANKRD20A2P | Q5SQ80 | 608 |
| FOXD4L3 | OR13C3 | Q8NGS6 | 480 |
| FOXD4L3 | OR13C4 | Q8NGS5 | 478 |
| FOXD4L3 | ZNF595 | Q8IYB9 | 450 |
| FOXD4L3 | MAP10 | Q9P2G4 | 419 |
| FOXD4L3 | GOLGA6L10 | A6NI86 | 417 |
| FOXD4L3 | ANKDD1B | A6NHY2 | 380 |
| FOXD4L3 | FOXR2 | Q6PJQ5 | 374 |
| FOXD4L3 | ARHGEF5 | Q12774 | 348 |
| FOXD4L3 | MYO18B | Q8IUG5 | 333 |
| FOXD4L3 | DUSP19 | Q8WTR2 | 317 |
| FOXD4L3 | RPL3L | Q92901 | 305 |
| FOXD4L3 | MUC12 | Q9UKN1 | 299 |
| FOXD4L3 | NBPF1 | Q3BBV0 | 293 |
| FOXD4L3 | WIPF2 | Q8TF74 | 290 |
IntAct
49 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOXD4L3 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KHDRBS2 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | RBPMS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CALCOCO2 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | PNMA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-2 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | PLEKHB2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BEX5 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOC1 | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPK | FOXD4L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4L3 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | KRTAP1-1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | KHDRBS2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | HNRNPK | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | RBPMS2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | CALCOCO2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | PNMA1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4L3 | KRTAP12-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), FOXD4L3 (Two-hybrid), KRTAP1-1 (Two-hybrid), CYSRT1 (Two-hybrid)
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0JNN8, A6NF83, A6NHQ4, A6QPM6, A8E4L3, A8MTW9, B2KGE5, C9JVW0, I3L1E1, O43541, O75474, O75638, P0C7X2, P70339, P89439, Q02080, Q05215, Q12950, Q3SYB3, Q5T230, Q5VV16, Q6NZ36, Q6NZY7, Q6P1X6, Q6VB84, Q6VUC0, Q6VUP9, Q6ZSJ8, Q7RTU5, Q7TNS8, Q80WY3, Q86SI9, Q86UU5, Q8K025
Diamond homologs: A0A078BQN7, A0A1W2PRP0, A0A8V0YY16, A1L1S5, A3KNJ3, A8MTJ6, A8XJN7, B5RHS5, D3Z120, F1R8Z9, O00358, O17617, O43638, O54743, O60129, O88470, P32027, P32028, P32030, P32315, P42128, P55316, P56260, P58012, P79772, P85037, P91278, Q00939, Q01167, Q02360, Q12946, Q12947, Q12948, Q12950, Q12951, Q12952, Q13461, Q19802, Q1A1A1, Q1A1A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
119 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 106 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
31 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:68303585:G:GT | donor_gain | 0.5300 |
| 9:68303933:A:T | donor_gain | 0.4600 |
| 9:68303554:G:GT | donor_gain | 0.4400 |
| 9:68303934:GA:G | donor_gain | 0.3400 |
| 9:68303878:G:GT | donor_gain | 0.3300 |
| 9:68303906:G:GT | donor_gain | 0.3300 |
| 9:68303935:A:AG | donor_gain | 0.3200 |
| 9:68303936:G:GG | donor_gain | 0.3200 |
| 9:68303906:G:T | donor_gain | 0.2800 |
| 9:68303912:G:GT | donor_gain | 0.2700 |
| 9:68303812:C:T | donor_gain | 0.2600 |
| 9:68304047:A:AG | acceptor_gain | 0.2500 |
| 9:68304048:G:GG | acceptor_gain | 0.2500 |
| 9:68304069:A:G | acceptor_gain | 0.2500 |
| 9:68303930:T:TG | donor_gain | 0.2400 |
| 9:68303939:T:TG | donor_gain | 0.2400 |
| 9:68303956:G:T | donor_gain | 0.2400 |
| 9:68304451:A:AG | acceptor_gain | 0.2400 |
| 9:68304451:AAAAT:A | acceptor_gain | 0.2400 |
| 9:68303586:G:T | donor_gain | 0.2300 |
| 9:68303905:G:GT | donor_gain | 0.2300 |
| 9:68303028:A:AG | donor_gain | 0.2200 |
| 9:68303067:TGG:T | donor_gain | 0.2200 |
| 9:68303801:A:T | donor_gain | 0.2200 |
| 9:68303051:G:GT | donor_gain | 0.2100 |
| 9:68303078:G:GT | donor_gain | 0.2100 |
| 9:68303856:ACTT:A | donor_gain | 0.2100 |
| 9:68303547:GGC:G | donor_gain | 0.2000 |
| 9:68303548:GCG:G | donor_gain | 0.2000 |
| 9:68303883:C:T | donor_gain | 0.2000 |
AlphaMissense
2679 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:68303405:T:A | W152R | 1.000 |
| 9:68303405:T:C | W152R | 1.000 |
| 9:68303407:G:C | W152C | 1.000 |
| 9:68303407:G:T | W152C | 1.000 |
| 9:68303418:T:A | I156N | 1.000 |
| 9:68303423:C:G | H158D | 1.000 |
| 9:68303447:T:C | F166L | 1.000 |
| 9:68303448:T:C | F166S | 1.000 |
| 9:68303448:T:G | F166C | 1.000 |
| 9:68303449:C:A | F166L | 1.000 |
| 9:68303449:C:G | F166L | 1.000 |
| 9:68303497:G:C | W182C | 1.000 |
| 9:68303497:G:T | W182C | 1.000 |
| 9:68303360:T:C | F137L | 0.999 |
| 9:68303362:C:A | F137L | 0.999 |
| 9:68303362:C:G | F137L | 0.999 |
| 9:68303375:T:C | F142L | 0.999 |
| 9:68303377:C:A | F142L | 0.999 |
| 9:68303377:C:G | F142L | 0.999 |
| 9:68303418:T:C | I156T | 0.999 |
| 9:68303418:T:G | I156S | 0.999 |
| 9:68303425:C:A | H158Q | 0.999 |
| 9:68303425:C:G | H158Q | 0.999 |
| 9:68303426:A:G | N159D | 0.999 |
| 9:68303428:C:A | N159K | 0.999 |
| 9:68303428:C:G | N159K | 0.999 |
| 9:68303430:T:A | L160H | 0.999 |
| 9:68303430:T:C | L160P | 0.999 |
| 9:68303439:A:T | N163I | 0.999 |
| 9:68303440:C:A | N163K | 0.999 |
dbSNP variants (sampled 300 via entrez): RS10120724 (9:68302311 A>G), RS10781365 (9:68303626 C>A,G,T), RS112954110 (9:68303578 G>A,C), RS1133715 (9:68305303 C>A,G,T), RS1156686607 (9:68305504 G>A,T), RS1156811325 (9:68305078 G>C), RS1157494051 (9:68301338 G>A), RS1158405593 (9:68304407 A>G), RS1158578372 (9:68304174 C>A,T), RS1158648287 (9:68303793 C>A), RS1158808454 (9:68303200 C>G,T), RS1159063178 (9:68302710 G>A), RS1159074225 (9:68301746 T>A,C), RS1159136014 (9:68301582 C>G), RS1159638526 (9:68302274 A>G)
Disease associations
OMIM: gene MIM:611086 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| Calcitriol | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A1Y5 | SEES3-1V human FOXD4L3, clone1 | Embryonic stem cell | Male |
| CVCL_A1Y6 | SEES3-1V human FOXD4L3, clone2 | Embryonic stem cell | Male |
| CVCL_A1Y7 | SEES3-1V human FOXD4L3, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.